LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it will present at the Rodman and Renshaw 11th Annual Healthcare Conference on Friday September 11, 2009 at 2 p.m. eastern time at the New York Palace Hotel in New York City. IMUC’s President and Chief Executive Officer, Manish Singh, Ph.D., will present an overview of the company’s business and strategy at the event, which last year featured more than 500 presenting companies and 3,500 attendees.
